Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | Kaitlyn K.H. Goey, Sjoerd G. Elias, Harm van Tinteren, Miangela M. Lacle, Stefan M. Willems, Wendy W.J. de Leng, Eric Strengman, Celien Vreuls, Geert-Jan Creemers, Ankie Van Der Velden, Cornelis J. A. Punt, Miriam Koopman | ||||||||||||
Title | Predictive value of KRAS mutation status in metastatic colorectal cancer (mCRC) patients treated with capecitabine and bevacizumab (CAP-B) maintenance treatment vs observation in the phase III CAIRO3 study. | ||||||||||||
|
|||||||||||||
URL | http://meetinglibrary.asco.org/content/162510-176 | ||||||||||||
Abstract Text | J Clin Oncol 34, 2016 (suppl; abstr 3525) |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|